Edwards Lifesciences (EW) Misses Q4 EPS by 3c, Offers Q1 and FY Guidance
Get Alerts EW Hot Sheet
EPS Growth %: +3.2%
Financial Fact:
Interest (income) expense, net: 2.1M
Today's EPS Names:
NLY, CP, RUSHA, More
Join SI Premium – FREE
Edwards Lifesciences (NYSE: EW) reported Q4 EPS of $0.50, $0.03 worse than the analyst estimate of $0.53. Revenue for the quarter came in at $1.2 billion versus the consensus estimate of $1.19 billion.
GUIDANCE:
Edwards Lifesciences sees Q1 2021 EPS of $0.43-$0.53, versus the consensus of $0.50. Edwards Lifesciences sees Q1 2021 revenue of $1.1-1.2 billion, versus the consensus of $1.21 billion.
Edwards Lifesciences sees FY2021 EPS of $2.00-$2.10, versus the consensus of $2.15. Edwards Lifesciences sees FY2021 revenue of $4.9-5.3 billion, versus the consensus of $5.09 billion.
For earnings history and earnings-related data on Edwards Lifesciences (EW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Oceaneering (OII) Tops Q1 EPS by 5c, confirms prior guidance
- Alamos Gold (AGI) Misses Q1 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!